Telehealth visits available in New York and Washington, DC
Natasha Giddens, MD, MS Psychiatry & Translational Research

Research

Publications

Research from Dr. Giddens's work at the National Institutes of Health and the University of Wisconsin on sleep, substance use, and the brain.

  1. Blunted modulation of hierarchical brain organization in opioid use disorder

    Tomasi D, Manza P, Demiral ŞB, Giddens N, Belcher A, Yan W, Miller KB, Veenker FN, Lildharrie C, Yonga MV, Abey S, Brucar L, VanDine M, Wang GJ, Volkow ND. Research Square [Preprint]. 2026.

    doi:10.21203/rs.3.rs-9889932/v1 · PMID: 42466414

  2. Adiposity and inflammation mediate altered metabolic profile in individuals with opioid use disorder

    Li X, Manza P, Wang GJ, Giddens N, Belcher A, Schwandt M, Diazgranados N, Lynch KG, Volkow ND, Shi Z, Wiers CE. Journal of Psychiatric Research. 2026 Oct;201:190–197.

    doi:10.1016/j.jpsychires.2026.06.021 · PMID: 42335491

  3. Adiposity and inflammation mediate altered metabolic profiles in individuals with opioid use disorder

    Li X, Manza P, Wang GJ, Giddens N, Belcher A, Schwandt M, Diazgranados N, Lynch KG, Volkow ND, Shi Z, Wiers CE. medRxiv [Preprint]. 2026 Apr 18.

    doi:10.64898/2026.04.13.26350800 · PMID: 42064932

  4. Rest-activity rhythms, their modulators, and brain-clinical correlates in opioid use disorder

    Zhang R, Manza P, Demiral SB, Tomasi D, Yonga MV, Yan W, Shokri-Kojori E, Schwandt M, Vines L, Sotelo D, Lildharrie C, Lin E, Giddens NT, Wang GJ, Volkow ND. JAMA Network Open. 2025 Feb 3;8(2):e2457976.

    doi:10.1001/jamanetworkopen.2024.57976 · PMID: 39903462 · PMCID: PMC11795329

  5. Rest-activity rhythms in opioid use disorder: associations with light exposure and brain state dynamics

    Zhang R, Manza P, Tomasi D, Yan W, Demiral SB, Shokri-Kojori E, Schwandt M, Vines L, Sotelo D, Lildharrie C, Lin E, Giddens NT, Wang GJ, Volkow ND. Neuropsychopharmacology. 2024;49(Suppl 1):299–300. ACNP Annual Meeting, December 2024.

  6. Elevated inflammatory state mediated altered lipid profiles in individuals with opioid use disorder

    Li X, Manza P, Wang GJ, Giddens N, Volkow ND, Shi Z, Wiers CE. Neuropsychopharmacology. 2024;49(Suppl 1):251–252. ACNP Annual Meeting, December 2024.

  7. Disrupted brain state dynamics in opioid and alcohol use disorder: attenuation by nicotine use

    Zhang R, Yan W, Manza P, Shokri-Kojori E, Demiral SB, Schwandt M, Vines L, Sotelo D, Tomasi D, Giddens NT, Wang GJ, Diazgranados N, Momenan R, Volkow ND. Neuropsychopharmacology. 2024 Apr;49(5):876–884. Epub 2023 Nov 6.

    doi:10.1038/s41386-023-01750-w · PMID: 37935861

  8. Neurological, behavioral, and pathophysiological characterization of the co-occurrence of substance use and HIV: a narrative review

    Vines L, Sotelo D, Giddens N, Manza P, Volkow ND, Wang GJ. Brain Sciences. 2023 Oct 19;13(10):1480.

    doi:10.3390/brainsci13101480 · PMID: 37891847 · PMCID: PMC10605099

  9. Disparities in sleep duration among American children: effects of race and ethnicity, income, age, and sex

    Giddens NT, Juneau P, Manza P, Wiers CE, Volkow ND. Proceedings of the National Academy of Sciences. 2022 Jul 26;119(30):e2120009119.

    doi:10.1073/pnas.2120009119 · PMID: 35858412 · PMCID: PMC9335336

  10. Cortical D1 and D2 dopamine receptor availability modulate methylphenidate-induced changes in brain activity and functional connectivity

    Manza P, Shokri-Kojori E, Demiral ŞB, Wiers CE, Zhang R, Giddens NT, McPherson K, Biesecker E, Dennis E, Johnson A, Tomasi D, Wang GJ, Volkow ND. Communications Biology. 2022 May 30;5(1):514.

    doi:10.1038/s42003-022-03434-5 · PMID: 35637272 · PMCID: PMC9151821

Abstracts and presentations

  1. Failure to thrive and malnutrition in an adult with OCD: an inpatient multidisciplinary approach to management of co-morbid ARFID in the general hospital

    Giddens NT, Thertus K. Poster, Academy of Consultation-Liaison Psychiatry Annual Meeting. Journal of the Academy of Consultation-Liaison Psychiatry. 2023.

Profiles